CCN5 and lung adenocarcinoma: First, we investigated to what extent full-length CCN5 (HHS-CCN5(FL)) or the TSP1 domain of CCN5 (HHS-CCN5(III)) would inhibit phospho-AKT (Ser473) levels in A549 human lung adenocarcinoma cells.